HEAL is trading 3.06% up now at $29.96, consistent with broader risk appetite after the U.S. Treasury increased planned long-term bond buybacks, lowering yields and supporting growth-sensitive assets.

  • HEAL closed at $29.07 on August 18.
  • No credible company-specific catalyst was identified for August 19, 2026.
  • The BioMarin–Alesta acquisition concerns BioMarin and is unrelated to HEAL.